黑地雷方联合艾瑞昔布治疗风湿热痹型骨关节炎的疗效OACSTPCD
Clinical effect of Heidilei Decoction combined with imrecoxib on osteoarthritis with wind dampness heat Bi syndrome
目的 观察黑地雷方联合艾瑞昔布治疗风湿热痹型骨关节炎的临床疗效,评价其对基质金属蛋白酶 9(MMP-9)及组织金属蛋白酶抑制因子 1(TIMP-1)的影响.方法 选取 2021-04 至 2023-04 在武警北京总队医院外二科就诊的风湿热痹型骨关节炎患者 63 例,随机分为对照组(艾瑞昔布片,n=31)和联合治疗组(黑地雷方+艾瑞昔布片,n=32),疗程 4 周,进行疼痛视觉模拟量表(VAS)、加拿大西安大略—麦克马斯特大学骨关节炎评分(WOM…查看全部>>
Objective To evaluate the clinical efficacy of of Heidilei Decoction combined with imrecoxib(CHDI)on osteoar-thritis with wind dampness heat Bi syndrome(OA-WDHB)and its effect on matrix metalloproteinases(MMPs)and tissue inhibitor of matrix metalloproteinases(TIMPs)expression.Methods A total of 63 OA-WDHB patients who attended the Beijing Municipal Corps Hospital of Chinese People's Armed Police Force from April 2021 to April 2023 were selected,and randomly …查看全部>>
黄楠;张军;武永刚;郭浩;余磊;梁宏伟;赵宝峰
100027,武警北京总队医院外二科100027,武警北京总队医院外二科100027,武警北京总队医院外二科100027,武警北京总队医院外二科100027,武警北京总队医院外二科100027,武警北京总队医院外二科100027,武警北京总队医院外二科
临床医学
骨关节炎风湿热痹黑地雷方基质金属蛋白酶9组织金属蛋白酶抑制因子1
osteoarthritiswind dampness heat Bi syndromeHeidilei Decoctionmatrix metalloproteinase-9tissue inhibitor of matrix metalloproteinases-1
《武警医学》 2024 (2)
121-124,129,5
评论